Screener
Ionis Pharmaceuticals IONS Effective Income Tax Rate Reconciliation, FDII, Amount
Effective Income Tax Rate Reconciliation, FDII, Amount at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount.
The source filing: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026.
- Filed
- Feb 26, 2026, 4:25 PM EST
- Fiscal year
- FY2026
- Accession
- 0000874015-26-000115
| Line item | Year Ended December 31, 2024 | Year Ended December 31, 2023 |
|---|---|---|
| Tax credits | (53,497)% | (67,131)% |
| Tax rate change | 10,815 | 1,023 |
| Non-deductible compensation | 1,895 | 3,814 |
| Other non-deductible items | 188% | 327 |
| Foreign-derived intangible income benefit | (21,071)% | (7,493)% |
| Stock-based compensation | 10,732 | 19,546 |
| Other | 665 | (401)% |
| Effective rate | $(6,171)% | $32,321 |
Item 15. Exhibits and Financial Statement Schedules
FAQ
- What is Ionis Pharmaceuticals's effective income tax rate reconciliation, FDII, amount?
- Ionis Pharmaceuticals (IONS) reported effective income tax rate reconciliation, FDII, amount of $5.27M in Q4 2024.
- How has Ionis Pharmaceuticals's effective income tax rate reconciliation, FDII, amount changed year-over-year?
- Ionis Pharmaceuticals's effective income tax rate reconciliation, FDII, amount increased by 181.2% year-over-year, from $1.87M to $5.27M.
- What does effective income tax rate reconciliation, FDII, amount mean?
- Represents the dollar value of the Foreign-Derived Intangible Income (FDII) deduction, which provides a lower tax rate on income derived from serving foreign markets using domestic intangible assets.
Ask your AI about Ionis Pharmaceuticals's effective income tax rate reconciliation, fdii, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude